Enhanced mTOR pathway activation has been reported in LEAT, such as GG and DNT [4, 14, 65, 78], suggesting a pathogenic link between these tumor entities and focal MCD, such as FCD ILAE Type IIb and cortical tubers in tuberous sclerosis complex (TSC), [23, 49]. The gene discussed is MTOR; the disease is neoplasm.